A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer.

Authors :: Jiang Z
Ouyang Q
Sun T
Zhang Q
Teng Y
Cui J
Wang H
Yin Y
Wang X
Zhou X
Wang Y
Sun G
Wang J
Zhang L
Yang J
Qian J
Yan M
Liu X
Yi T
Cheng Y
Li M
Zang A
Wang S
Wang C
Wu X
Cheng J
Li H
Lin Y
Geng C
Gu K
Xie C
Xiong H
Wu X
Yang J
Li Q
Chen Y
Li F
Zhang A
Zhang Y
Wu Y
Nie J
Liu Q
Wang K
Mo X
Chen L
Pan Y
Fu P
Zhang H
Pang D
Sheng Y
Han Y
Wang H
Cang S
Luo X
Yu W
Deng R
Yang C
Keegan P
Source :: Future oncology (London, England) [Future Oncol] 2025 Feb; Vol. 21 (4), pp. 421-429. Date of Electronic Publication: 2024 Dec 04.
Publication Year :: 2025

Full Text Access

Tools